Skip to content
No picture yet

PMS-Letrozole 2.5 mg – DIN 02309114

PMS-Letrozole is Letrozole 2.5 mg (tablet), sold in Canada. It is used for breast cancer. It is supplied by Pharmascience Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.

Sold in Canada

Letrozole 2.5 mg

Brand
PMS-Letrozole
Strength
2.5 mg
Used for
Breast cancer
Form
Tablet
Manufacturer
Pharmascience Inc
Drug class
Breast cancer medicine (aromatase inhibitor)
Sold in
Canada
DIN
02309114

Source: Health Canada's Drug Product Database. Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Letrozole pills and guides

What is Letrozole used for?

Letrozole is used for breast cancer.

Medicine type
Breast cancer medicine (aromatase inhibitor)
Official uses from the US prescribing label

Adjuvant Treatment of Early Breast Cancer

Letrozole tablets are indicated for the adjuvant treatment of postmenopausal women with hormone receptor positive early breast cancer.

Extended Adjuvant Treatment of Early Breast Cancer

Letrozole tablets are indicated for the extended adjuvant treatment of early breast cancer in postmenopausal women, who have received 5 years of adjuvant tamoxifen therapy. The effectiveness of letrozole tablets in extended adjuvant treatment of early breast cancer is based on an analysis of disease-free survival (DFS) in patients treated with letrozole tablets for a median of 60 months.

First and Second-Line Treatment of Advanced Breast Cancer

Letrozole tablets are indicated for first-line treatment of postmenopausal women with hormone receptor positive or unknown, locally advanced or metastatic breast cancer. Letrozole tablets are also indicated for the treatment of advanced breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

From the FDA-approved label on DailyMed (published Aug 21, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your medicine? Check the box

  • The box or bottle shows DIN 02309114.
  • It names PMS-Letrozole, Letrozole 2.5 mg.
  • A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.

Sold in Canada as PMS-Letrozole by Pharmascience Inc.

In Canada: prescription only.

Ingredients

Active: Letrozole

Other Letrozole pills